Presentation Ashwani VermaUBS Investment Bank, Research Division All right. Good day, everybody. My name is Ash Verma. I cover SMID cap biotech and spec pharma. And with us, we have PTC Therapeutics, Matt Klein, who is the CEO; and Pierre Gravier, who is the CFO. Guys, thank you for joining us. Matthew KleinCEO & Director Thank you, Ash. Great to be here. Ashwani VermaUBS Investment Bank, Research Division So exciting time in the story with the launch of Sephience. Maybe if you can give a little bit of a ...